Bionik Laboratories Corp. (BNKL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5 Million USD | 186.09% |
| 2022 | 1.74 Million USD | -68.24% |
| 2021 | 5.5 Million USD | 5.87% |
| 2020 | 5.19 Million USD | 59.02% |
| 2019 | 3.26 Million USD | -59.74% |
| 2018 | 8.12 Million USD | 40.57% |
| 2017 | 5.77 Million USD | -3.27% |
| 2016 | 5.97 Million USD | 13927.34% |
| 2015 | 42.58 Thousand USD | 199.18% |
| 2014 | 14.23 Thousand USD | 762.55% |
| 2013 | 1650.00 USD | -73.94% |
| 2012 | 6332.00 USD | 5.53% |
| 2011 | 6000.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | - USD | -100.0% |
| 2024 Q2 | - USD | 0.0% |
| 2023 Q3 | 4.2 Million USD | 27.22% |
| 2023 Q4 | 5 Million USD | 18.91% |
| 2023 FY | 5 Million USD | 186.09% |
| 2023 Q1 | 2.4 Million USD | 37.61% |
| 2023 Q2 | 3.3 Million USD | 37.43% |
| 2022 Q2 | 10.12 Million USD | 75.78% |
| 2022 Q3 | 10.42 Million USD | 2.94% |
| 2022 Q4 | 1.74 Million USD | -83.22% |
| 2022 FY | 1.74 Million USD | -68.24% |
| 2022 Q1 | 5.75 Million USD | 4.63% |
| 2021 Q1 | 6.99 Million USD | 34.56% |
| 2021 Q3 | 7.52 Million USD | 9.15% |
| 2021 Q4 | 5.5 Million USD | -26.85% |
| 2021 FY | 5.5 Million USD | 5.87% |
| 2021 Q2 | 6.89 Million USD | -1.45% |
| 2020 FY | 5.19 Million USD | 59.02% |
| 2020 Q1 | 4.65 Million USD | 42.39% |
| 2020 Q2 | 3.25 Million USD | -29.98% |
| 2020 Q3 | 2.66 Million USD | -18.34% |
| 2020 Q4 | 5.19 Million USD | 95.32% |
| 2019 Q2 | 2 Million USD | -61.05% |
| 2019 FY | 3.26 Million USD | -59.74% |
| 2019 Q4 | 3.26 Million USD | -48.25% |
| 2019 Q3 | 6.31 Million USD | 215.46% |
| 2019 Q1 | 5.14 Million USD | -36.69% |
| 2018 Q1 | 6.36 Million USD | 10.18% |
| 2018 FY | 8.12 Million USD | 40.57% |
| 2018 Q4 | 8.12 Million USD | -21.2% |
| 2018 Q3 | 10.3 Million USD | 45.47% |
| 2018 Q2 | 7.08 Million USD | 11.3% |
| 2017 Q1 | 7.41 Million USD | 24.1% |
| 2017 Q4 | 5.77 Million USD | 15.52% |
| 2017 FY | 5.77 Million USD | -3.27% |
| 2017 Q2 | 5.39 Million USD | -27.27% |
| 2017 Q3 | 5 Million USD | -7.22% |
| 2016 Q1 | 230.35 Thousand USD | -57.48% |
| 2016 FY | 5.97 Million USD | 13927.34% |
| 2016 Q2 | 249.62 Thousand USD | 8.37% |
| 2016 Q4 | 5.97 Million USD | -4.59% |
| 2016 Q3 | 6.26 Million USD | 2407.9% |
| 2015 Q2 | 24.45 Thousand USD | 13.1% |
| 2015 Q1 | 21.62 Thousand USD | 30.25% |
| 2015 Q4 | 541.73 Thousand USD | 1172.27% |
| 2015 FY | 42.58 Thousand USD | 199.18% |
| 2015 Q3 | 42.58 Thousand USD | 74.09% |
| 2014 Q4 | 16.6 Thousand USD | 16.67% |
| 2014 Q2 | 10.14 Thousand USD | 46.71% |
| 2014 Q1 | 6915.00 USD | 4510.0% |
| 2014 FY | 14.23 Thousand USD | 762.55% |
| 2014 Q3 | 14.23 Thousand USD | 40.29% |
| 2013 Q4 | 150.00 USD | -90.91% |
| 2013 Q1 | 6515.00 USD | 1.4% |
| 2013 Q2 | 6605.00 USD | 1.38% |
| 2013 Q3 | 1650.00 USD | -75.02% |
| 2013 FY | 1650.00 USD | -73.94% |
| 2012 Q3 | 6332.00 USD | 3.97% |
| 2012 Q2 | 6090.00 USD | 0.0% |
| 2012 FY | 6332.00 USD | 5.53% |
| 2012 Q4 | 6425.00 USD | 1.47% |
| 2011 FY | 6000.00 USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| The Amacore Group, Inc. | 24.7 Million USD | 79.754% |
| Arem Pacific Corporation | 304.9 Thousand USD | -1540.756% |
| Assisted 4 Living, Inc. | 184.16 Thousand USD | -2616.401% |
| BioCorRx Inc. | 10.34 Million USD | 51.624% |
| Banyan Corp. | 4.51 Million USD | -10.718% |
| Clearday, Inc. | 65.13 Million USD | 92.319% |
| Dental Patient Care America, Inc. | 1.8 Million USD | -177.605% |
| Quantum Medical Transport, Inc. | 1504.02 USD | -332522.904% |
| Empower Clinics Inc. | 9.18 Million USD | 45.538% |
| First Choice Healthcare Solutions, Inc. | 31.65 Million USD | 84.195% |
| Selectis Health, Inc. | 43.63 Million USD | 88.535% |
| Ethema Health Corporation | 17.71 Million USD | 71.767% |
| HealthLynked Corp. | 3.47 Million USD | -43.946% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.47 Million USD | 65.438% |
| JRSIS Health Care Corporation | 2.3 Million USD | -117.021% |
| Comjoyful International Company | 6.32 Million USD | 20.919% |
| Medical Facilities Corporation | 235.37 Million USD | 97.875% |
| MedSmart Group Inc. | 927.53 Thousand USD | -439.358% |
| North America Frac Sand, Inc. | 936.85 Thousand USD | -433.993% |
| Nova Leap Health Corp. | 2.69 Million USD | -85.357% |
| Nexteligent Holdings, Inc. | 2.88 Million USD | -73.577% |
| PAO Group, Inc. | 1.04 Million USD | -378.014% |
| Primemd Inc. | 7.98 Million USD | 37.378% |
| Raffles Medical Group Ltd | 367.04 Million USD | 98.637% |
| Ryman Healthcare Limited | 5.17 Billion USD | 99.903% |
| Stem Cell Authority, Ltd. | 80.52 Thousand USD | -6112.623% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 3.91 Million USD | -27.757% |
| Mycotopia Therapies, Inc. | 4.24 Million USD | -17.774% |
| U.S. NeuroSurgical Holdings, Inc. | 676 Thousand USD | -640.047% |
| Veltex Corporation | 2.87 Million USD | -73.872% |
| World Financial Holding Group | 132.5 Thousand USD | -3675.491% |
| Xcelerate Inc. | 2.07 Million USD | -141.028% |